Table 3.
Immunological parameters: difference between treatment group (aVQ) and control group by independentt-test and result of the repeated measured analysis of variance (ANOVA, influence of treatment)
| |
Values at baseline (SD) |
Difference between aVQ and control |
|||||
|---|---|---|---|---|---|---|---|
| |
aVQ |
Control |
t |
t |
t |
t |
F |
| baseline | week 8 | week 16 | week 24 | ANOVA | |||
| CD 16+/CD 56+ |
10.5 (4.16) |
9.38 (3.61) |
−0.816 |
−0.3458 |
−0.452 |
−0.2512 |
0.2823 |
| CD 19+ |
21.06 (13.71) |
20.25 (8.97) |
−0.198 |
0.2786 |
0.1885 |
0.3131 |
0.0199 |
| TNF-α |
2.18 (1.61) |
1.6 (0.49) |
−1.381 |
−1.4135 |
−0.407 |
−1.6893 |
2.7911 |
| IL-2 | 1.04 (0.56) | 0.94 (0.44) | −0.58 | −1.0269 | −1.34 | −1.019 | 2.1181 |
SD: standard deviation; CD 16+/CD 56+ : lymphocytes with CD 16+/CD 56+ (NK-cells), CD 19+ : lymphocytes with CD 19+, TNF-α: tumor necrosis factor alpha, IL-2: interleukin-2.